Hormonal imbalances originating from the pituitary and adrenal gland disorders significantly affect metabolic regulation, stress response, and glucose homeostasis. Conditions such as Cushing’s syndrome, Addison’s disease, and acromegaly disrupt normal endocrine signaling, contributing to insulin resistance, hypertension, and cardiovascular complications. Advances in endocrinology have led to targeted therapies, including hormone replacement and receptor-specific drugs, to restore balance. Imaging technologies and molecular diagnostics have improved early detection, allowing for timely interventions. Understanding the connections between pituitary-adrenal dysfunction and metabolic diseases enables the development of more precise treatment strategies. Ongoing research continues to refine therapeutic options, offering new hope for patients with complex endocrine disorders.
Mahir Khalil Ibrahim Jallo
Gulf Medical University, Canada
Yong Xiao Wang
Albany Medical College, United States
F Buck Willis
University of Belize, Belize
Sujith Rajan
NYU Long Island School of Medicine, United States
Amy Gutman
AdventHealth; Tough Love MD, United States
Paraskevi Theofilou
Hellenic Open University, Greece
Teji S Dhami
Boost your Health and Wellness, United StatesSubmit your abstract Today
Title : Adipose MTP deficiency protects against hepatic steatosis by upregulating PPAR activity
Sujith Rajan, NYU Long Island School of Medicine, United States
Title : Important roles and mechanisms of novel calcium signaling in diabetes-induced vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : Does winter melon (Benincasa hispida) improves nutritional values and ameliorating glycaemic parameters ?
Wan Rosli Wan Ishak, Universiti Sains Malaysia, Malaysia
Title : The menopausal mind: Reframing female senescence as a neuroendocrine disorder with root cause management strategies
Amy Gutman, AdventHealth; Tough Love MD, United States
Title : Diabetes reduction (pre-diabetes and type 2) with integrative medicine
F Buck Willis, University of Belize, Belize
Title : Serum fructosamine: A more accurate screening test than 3-hour OGTT for diagnosis of gestational diabetes
Sarah Exley, Broadlawns Medical Center, United States